SMYD3 and cancer: The histone-lysine N-methyltransferase SMYD3 has been found overexpressed in several human cancers and has been linked to multiple cancer-related mechanisms, such as cell cycle deregulation, uncontrolled cell proliferation, migration and invasion, deregulated chromatin remodeling, altered gene expression, and histone and non-histone protein methylation [1].